Immupharma

IMM · AIM · Health Care · mcap £21m · 4.0p

Beta Briefing, track record and bull & bear case are not ready for Immupharma yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 61 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Jun 26

Source: results 15 Sep 26 ↗

Revenue: £0k
Operating profit: −£2.5m
Net income: −£5.3m
Free cash flow: −£1.9m
Net cash: £696k
Market cap: £20.1m
EV / EBIT: –
FCF yield: −9.2%
Price / book: 11.0×

Latest half-year · H1 26 vs H1 25 results 15 Sep 26 ↗

Operating profit: −£1.1m
Net income: −£4.7m
Cash from operations: −£480k

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H1 26 (six months to 30 Jun 26), published 15 Sep 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	LTM Jun 26	FY 25	FY 24
Revenue	–	0.0	0.0
Operating profit	(2.5)	(2.7)	(2.7)
Share-based payments	(0.1)	(0.1)	(0.1)
Finance costs	(3.0)	(0.1)	(0.1)
Profit before tax	(5.5)	(2.8)	(2.8)
Tax	0.2	0.3	0.3
Net income (owners)	(5.3)	(2.5)	(2.5)
EPS basic	(1.1p)	(0.6p)	(0.6p)
EPS diluted	(1.1p)	(0.6p)	(0.6p)

	H1 26	vs H1 25	H2 25	H1 25
Operating profit	(1.1)	n/m	(1.4)	(1.2)
Share-based payments	(0.0)	n/m	(0.0)	(0.1)
Finance costs	(3.6)	+390%	0.6	(0.7)
Profit before tax	(4.7)	n/m	(0.8)	(1.9)
Tax	0.0	n/m	0.2	0.1
Net income (owners)	(4.7)	n/m	(0.6)	(1.8)
EPS basic	(0.8p)	–	(0.2p)	(0.4p)
EPS diluted	(0.8p)	–	(0.2p)	(0.4p)

	LTM Jun 26	FY 25	FY 24
Cash from operations	(1.8)	(2.4)	(1.8)
Interest paid	(0.0)	(0.0)	0.0
Tax paid	–	0.3	0.3
Capex (PP&E)	(0.0)	(0.0)	–
Shares issued	3.7	1.3	0.0

	H1 26	vs H1 25	H2 25	H1 25
Cash from operations	(0.5)	n/m	(1.4)	(1.0)
Interest paid	(0.0)	n/m	(0.0)	(0.0)
Capex (PP&E)	(0.0)	n/m	(0.0)	0.0
Shares issued	5.5	+82%	(1.7)	3.0

	Latest Jun 26	FY 25	FY 24
Other intangibles	–	0.0	0.0
Property, plant & equipment	0.1	0.1	0.1
Trade receivables	0.3	0.2	0.3
Cash	0.7	1.4	0.2
Current assets	1.7	1.8	0.9
Trade payables	1.3	1.2	1.5
Current liabilities	1.3	1.2	1.5
Total equity	1.8	0.7	(0.5)
Shares in issue	–	787.7m	701.4m

	H1 26	H2 25	H1 25	H2 24
Other intangibles	–	0.0	–	0.0
Property, plant & equipment	0.1	0.1	0.1	0.1
Trade receivables	0.3	0.2	0.2	0.3
Cash	0.7	1.4	0.4	0.2
Current assets	1.7	1.8	1.5	0.9
Trade payables	1.3	1.2	1.2	1.5
Current liabilities	1.3	1.2	1.2	1.5
Total equity	1.8	0.7	0.3	(0.5)
Shares in issue	–	787.7m	–	701.4m

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.